| Wesley P Fairfield, MD, ECNU | |
|
144 State St Fl 4, Portland, ME 04101-3776 | |
| (207) 400-8500 | |
| (207) 400-8508 |
| Full Name | Wesley P Fairfield |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 29 Years |
| Location | 144 State St Fl 4, Portland, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437138955 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 015822 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Light Mercy Hospital | Portland, ME | Hospital |
| Central Maine Medical Center | Lewiston, ME | Hospital |
| Stephens Memorial Hospital | Norway, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Hospital | 6103737812 | 207 |
News Archive
The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.
The COVID-19 pandemic has now claimed over 2 million deaths worldwide, and this number is only increasing. In response, health agencies have rolled out tests to diagnose and understand the disease.
According to a union some Queensland Health professionals are ready to strike over a government wage offer. The Liquor, Hospitality and Miscellaneous Workers Union (LHMWU) and Queensland Public Sector Union (QPSU) (that includes radiographers, scientists and pharmacists) started this campaign across Queensland on Monday. They are protesting even on radio and print ads for a 2.5 per cent rise a year, over three years.
Wilson Therapeutics, a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partners LLP. The company's founding investor, HealthCap, also participated in the round.
› Verified 9 days ago
| Entity Name | Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.
The COVID-19 pandemic has now claimed over 2 million deaths worldwide, and this number is only increasing. In response, health agencies have rolled out tests to diagnose and understand the disease.
According to a union some Queensland Health professionals are ready to strike over a government wage offer. The Liquor, Hospitality and Miscellaneous Workers Union (LHMWU) and Queensland Public Sector Union (QPSU) (that includes radiographers, scientists and pharmacists) started this campaign across Queensland on Monday. They are protesting even on radio and print ads for a 2.5 per cent rise a year, over three years.
Wilson Therapeutics, a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partners LLP. The company's founding investor, HealthCap, also participated in the round.
› Verified 9 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.
The COVID-19 pandemic has now claimed over 2 million deaths worldwide, and this number is only increasing. In response, health agencies have rolled out tests to diagnose and understand the disease.
According to a union some Queensland Health professionals are ready to strike over a government wage offer. The Liquor, Hospitality and Miscellaneous Workers Union (LHMWU) and Queensland Public Sector Union (QPSU) (that includes radiographers, scientists and pharmacists) started this campaign across Queensland on Monday. They are protesting even on radio and print ads for a 2.5 per cent rise a year, over three years.
Wilson Therapeutics, a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partners LLP. The company's founding investor, HealthCap, also participated in the round.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wesley P Fairfield, MD, ECNU 287 Main St, Lewiston, ME 04240-7054 Ph: (207) 795-7520 | Wesley P Fairfield, MD, ECNU 144 State St Fl 4, Portland, ME 04101-3776 Ph: (207) 400-8500 |
News Archive
The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.
The COVID-19 pandemic has now claimed over 2 million deaths worldwide, and this number is only increasing. In response, health agencies have rolled out tests to diagnose and understand the disease.
According to a union some Queensland Health professionals are ready to strike over a government wage offer. The Liquor, Hospitality and Miscellaneous Workers Union (LHMWU) and Queensland Public Sector Union (QPSU) (that includes radiographers, scientists and pharmacists) started this campaign across Queensland on Monday. They are protesting even on radio and print ads for a 2.5 per cent rise a year, over three years.
Wilson Therapeutics, a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partners LLP. The company's founding investor, HealthCap, also participated in the round.
› Verified 9 days ago
Andrew J. Hsu, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 155 Fore River Pkwy, Portland, ME 04102 Phone: 207-535-1100 Fax: 207-879-8787 | |
David A Polisner, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Dr. Elizabeth A Jacobs, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Brian D Moore, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Marc Stuart Hoffman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3265 | |
Janet D Mcculley, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-4618 | |
Saeeda Fatima, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St Rm 2227, Portland, ME 04102 Phone: 207-662-4618 |